Skip to content

Effectiveness of Homoeopathic Medicine in the Treatment of Migraine Selected Using Boger Boenninghausens Characteristics & Repertory

Effectiveness of Homoeopathic Medicine in the Treatment of Migraine Selected Using Boger Boenninghausens Characteristics & Repertory : an open, observational, prospective, clinical study - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/07/055563
Enrollment
40
Registered
2023-07-24
Start date
Unknown
Completion date
Unknown
Last updated
2023-08-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: G439- Migraine, unspecified

Interventions

Intervention1: HOMOEOPATHIC MEDICINE: Intervention is planned as administering indicated homoeopathic medicines selected with the help of Boger Boenninghausenâ??s Characteristics & Repertory, in cent

Sponsors

NATIONAL INSTITUTE OF HOMOEOPATHY
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: a) Patients suffering from migraine fulfilling the criteria of the 3rd edition of International Classification of Headache (ICHD-3) b) Patients of age between 18 -50 years. c) Patients of both sexes and all religions will be taken for study. d) Patients willing to take part in the study. e) Patients, who are able to read, write or understand Bengali or English or Hindi.

Exclusion criteria

Exclusion criteria: a) Patients having headache other than migraine (not fulfilling criteria of ICHD-3 for migraine) b) Patients who are too sick for consultation. c) Diagnosed cases of unstable psychiatric illness or other life- threatening disease affecting quality of life or any organ failure. d) Currently receiving homoeopathic treatment for any chronic condition. e) Pregnant and lactating women. f) Patients not willing to participate in the study

Design outcomes

Primary

MeasureTime frame
Outcome data will be recorded using Migraine Disability Assessment Score.Timepoint: At baseline and after 6 months.

Secondary

MeasureTime frame
NOT APPLICABLETimepoint: NOT APPLICABLE

Countries

India

Contacts

Public ContactDr AVIJIT SHEE BURMAN

NATIONAL INSTITUTE OF HOMOEOPATHY

asheeburman@gmail.com9674011524

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026